MRNA vs OCGN · rev $145.0M vs rev $3.0M
Moderna Inc (MRNA) versus Ocugen Inc (OCGN) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Ocugen Inc (OCGN) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported OCGN revenue for 2026-06-30 was $3.0M. Net income was -$44.1M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
MRNA currently screens at market cap $24.52B. OCGN currently screens at market cap $416.4M.
Not investment advice. Open the MRNA and OCGN stock pages for the full models.
Not investment advice.